Per ulteriori informazioni selezionare i riferimenti di interesse.
Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemia
LEUKEMIA
Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage
LEUKEMIA
Optical processing of light-induced autofluorescence for characterization of tissue pathology
OPTICS LETTERS
Study on numerical simulation of mold filling and heat transfer in die casting process
JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia
LEUKEMIA
Numerical simulation of thermal stress and deformation of engine block iron casting
INTERNATIONAL JOURNAL OF CAST METALS RESEARCH
Numerical simulation of thermal stress of shaped casting based on rheological model
JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RAR alpha and NPM-RAR alpha
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
BLOOD
A STUDY OF THE INTERFACIAL HEAT-TRANSFER BETWEEN AN IRON CASTING AND A METALLIC MOLD
Journal of materials processing technology
STUDY ON A CAD CAE SYSTEM OF DIE-CASTING
Journal of materials processing technology
USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. AS2O3 EXERTS DOSE-DEPENDENT DUAL EFFECTS ON APL CELLS
Blood
USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APE) .2. CLINICAL EFFICACY AND PHARMACOKINETICS IN RELAPSED PATIENTS
Blood
OPTICAL COATINGS FOR DEUTERIUM FLUORIDE CHEMICAL-LASER SYSTEMS
Applied optics
USE OF ARSENTIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. ARSENIC CAUSES BOTH APOPTOSIS AND PARTIAL DIFFERENTIATION OF NB4 AND FRESH APL CELLS IN-VITRO AND IN-VIVO
Blood